Characterisation and sequencing of the novel phage Abp95, which is effective against multi-genotypes of carbapenem-resistant Acinetobacter baumannii

«Development of an anti- Acinetobacter baumannii biofilm phage cocktail: Genomic Adaptation to the Host»

(2022) L. Blasco et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development of Klebsiella pneumoniae Capsule Polysaccharide-Conjugated Vaccine Candidates Using Phage Depolymerases

(2022) Tzu-Lung Lin et al.   Frontiers in Immunology

The Specific Capsule Depolymerase of Phage PMK34 Sensitizes Acinetobacter baumannii to Serum Killing

(2022) Karim Abdelkader et al.   Antibiotics-Basel

Characterization of Novel Lytic Myoviridae Phage Infecting Multidrug-Resistant Acinetobacter baumannii and Synergistic Antimicrobial Efficacy between Phage and Sacha Inchi Oil

(2022) Phitchayapak Wintachai et al.   Pharmaceuticals

A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient

(2021) David Lebeaux et al.   Viruses-Basel

Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients

(2021) Nannan Wu et al.   Emerging Microbes & Infections

Bacteriophage-Derived Depolymerases against Bacterial Biofilm

(2021) Gracja Topka-Bielecka et al.   Antibiotics-Basel

Acinetobacter baumannii: An Ancient Commensal with Weapons of a Pathogen

(2021) Meysam Sarshar et al.   Pathogens

Investigations on Acinetophage, QAB 3.4, Targeting Extensively Drug-Resistant Acinetobacter baumannii Isolates

(2021) Aamir Hussain et al.   Infection and Drug Resistance

Diversity and Function of Phage Encoded Depolymerases

(2020) Leandra E. Knecht et al.   Frontiers in Microbiology

Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa

(2020) Shukho Kim et al.   Journal of Global Antimicrobial Resistance

How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections

(2020) Majid Taati Moghadam et al.   Infection and Drug Resistance

Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety

(2020) Young Ran Lee et al.   CLINICAL DRUG INVESTIGATION

Phage Therapy for Limb-threatening Prosthetic Knee Klebsiella pneumoniae Infection: Case Report and In Vitro Characterization of Anti-biofilm Activity

(2020) Edison J Cano et al.   CLINICAL INFECTIOUS DISEASES

Management of Chronic Bacterial Prostatitis

(2020) Zhuo Tony Su et al.   Current Urology Reports

The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity

(2020) Yuyu Yuan et al.   Microbial Biotechnology

Investigating Bacteriophages Targeting the Opportunistic Pathogen Acinetobacter baumannii

(2020) Kathryn M. Styles et al.   Antibiotics-Basel

Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial

(2020) Lorenz Leitner et al.   LANCET INFECTIOUS DISEASES

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

(2020) Matteo Bassetti et al.   LANCET INFECTIOUS DISEASES

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

(2020) Richard G Wunderink et al.   LANCET INFECTIOUS DISEASES

Isolation and Characterization of a Novel Myophage Abp9 Against Pandrug Resistant Acinetobacater baumannii

(2020) Lingli Jiang et al.   Frontiers in Microbiology

Characterization, Antibiofilm, and Depolymerizing Activity of Two Phages Active on Carbapenem-Resistant Acinetobacter baumannii

(2020) Goran Vukotic et al.   Frontiers in Medicine

A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii

(2019) Minle Wu et al.   Frontiers in Microbiology

Characterization and genome annotation of a newly detected bacteriophage infecting multidrug-resistant Acinetobacter baumannii

(2019) Zichen Yang et al.   ARCHIVES OF VIROLOGY

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

(2019) Rebekah M. Dedrick et al.   NATURE MEDICINE

Early clinical experience of bacteriophage therapy in 3 lung transplant recipients

(2019) Saima Aslam et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy

(2019) Anca M Segall et al.   CURRENT OPINION IN MICROBIOLOGY

Use of Customized Bacteriophages in the Treatment of Chronic Nonhealing Wounds: A Prospective Study

(2019) Dev Raj Patel et al.   International Journal of Lower Extremity Wounds

Applications of Bacteriophages in the Treatment of Localized Infections in Humans

(2018) Vera V. Morozova et al.   Frontiers in Microbiology

Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial

(2018) Patrick Jault et al.   LANCET INFECTIOUS DISEASES

Canu: scalable and accurate long-read assembly via adaptivek-mer weighting and repeat separation

(2017) Sergey Koren et al.   GENOME RESEARCH

Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial

(2017) Joseph Solomkin et al.   JAMA Surgery

Characterization and complete genome sequence analysis of twoMyoviralbacteriophages infecting clinical carbapenem-resistantAcinetobacter baumanniiisolates

(2016) J. Jeon et al.   JOURNAL OF APPLIED MICROBIOLOGY

Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent

(2016) Ia Kusradze et al.   Frontiers in Microbiology

Multilocus Sequence Typing Analysis of Carbapenem-Resistant Acinetobacter baumannii in a Chinese Burns Institute

(2016) Guangtao Huang et al.   Frontiers in Microbiology

Ability of Bacteriophage in Resolving Wound Infection Caused by Multidrug-ResistantAcinetobacter baumanniiin Uncontrolled Diabetic Rats

(2015) VinodKumar Chickmangalure Shivaswamy et al.   Microbial Drug Resistance

A5-miseq: an updated pipeline to assemble microbial genomes from Illumina MiSeq data

(2014) David Coil et al.   BIOINFORMATICS

Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection

(2014) Shruti Bansal et al.   BMC INFECTIOUS DISEASES

Characterization and Detection of Endolysin Gene from Three Acinetobacter baumannii Bacteriophages Isolated from Sewage Water

(2014) Thawatchai Kitti et al.   INDIAN JOURNAL OF MICROBIOLOGY

Characterization and Genome Sequencing of Phage Abp1, a New phiKMV-Like Virus Infecting Multidrug-Resistant Acinetobacter baumannii

(2013) Guangtao Huang et al.   CURRENT MICROBIOLOGY

SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing

(2012) Anton Bankevich et al.   JOURNAL OF COMPUTATIONAL BIOLOGY

Rfam 11.0: 10 years of RNA families

(2012) Sarah W. Burge et al.   NUCLEIC ACIDS RESEARCH

Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity

(2011) Luísa C. S. Antunes et al.   PLoS One

Isolation and characterization of ϕAB2: a novel bacteriophage of Acinetobacter baumannii

(2010) Nien-Tsung Lin et al.   RESEARCH IN MICROBIOLOGY

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS